| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells. |
| Category: | Health & biotech |
| URL: | http://www.neurenpharma.com |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2001 |
| Address: | Camberwell, VIC 3124, AU |
| State: | Victoria |
| Overseas Operations: | No |
| Twitter: | [twitter-timeline username=”“] |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |
